{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:24:06Z","timestamp":1767990246658,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["D15D18000410001"],"award-info":[{"award-number":["D15D18000410001"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijantimicag.2024.107137","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T07:17:54Z","timestamp":1710746274000},"page":"107137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-9694","authenticated-orcid":false,"given":"Jessica","family":"Cusato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Manca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0860-280X","authenticated-orcid":false,"given":"Alice","family":"Palermiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Mula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Avataneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Marinaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Trunfio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-4126","authenticated-orcid":false,"given":"Antonio","family":"D'Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107137_bib0001","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QAD.0000000000000560","article-title":"Cerebral white matter integrity during primary HIV infection","volume":"29","author":"Wright","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0002","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/QAD.0000000000002806","article-title":"Comparison of dementia risk after age 50 between individuals with and without HIV infection","volume":"35","author":"Lam","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0003","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/QAD.0000000000003134","article-title":"Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016","volume":"36","author":"Lam","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0004","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fncel.2018.00307","article-title":"HIV neuroinfection and Alzheimer's disease: similarities and potential links?","volume":"12","author":"Canet","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0005","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00018-020-03711-8","article-title":"Mechanisms and therapeutic potential of interactions between human amyloids and viruses","volume":"78","author":"Michiels","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0006","doi-asserted-by":"crossref","first-page":"e77972","DOI":"10.1371\/journal.pone.0077972","article-title":"HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0007","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13365-018-0702-9","article-title":"The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease","volume":"25","author":"Rubin","year":"2019","journal-title":"J Neurovirol"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0009","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1523\/JNEUROSCI.3029-15.2016","article-title":"Pathological tau promotes neuronal damage by impairing ribosomal function and decreasing protein synthesis","volume":"36","author":"Meier","year":"2016","journal-title":"J Neurosci"},{"issue":"Pt 3","key":"10.1016\/j.ijantimicag.2024.107137_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj3230577","article-title":"Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration","volume":"323","author":"Billingsley","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0011","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbrc.2011.06.133","article-title":"A partially folded structure of amyloid-beta(1-40) in an aqueous environment","volume":"411","author":"Vivekanandan","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0012","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-2009-1154","article-title":"Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies","volume":"18","author":"Hiltunen","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0013","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/neuonc\/nov092","article-title":"CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma","volume":"17","author":"Viaccoz","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0014","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s13365-015-0371-x","article-title":"Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients","volume":"22","author":"Calcagno","year":"2016","journal-title":"J Neurovirol"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0015","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/diagnostics11050867","article-title":"Blood-brain barrier impairment in patients living with HIV: predictors and associated biomarkers","volume":"11","author":"Caligaris","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0016","first-page":"14","article-title":"Patterns of cerebrospinal fluid Alzheimer's dementia biomarkers in people living with HIV: cross-sectional study on associated factors according to viral control, neurological confounders and neurocognition","author":"Trunfio","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2587094","article-title":"Pharmacokinetic, Pharmacogenetic, and other factors influencing CNS penetration of antiretrovirals","author":"Nwogu","year":"2016","journal-title":"AIDS Res Treat"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0019","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jac\/dkt339","article-title":"High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis","volume":"69","author":"Calcagno","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0021","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dky481","article-title":"Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites","volume":"74","author":"Decloedt","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0022","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/QAD.0b013e3283553619","article-title":"Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics","volume":"26","author":"Calcagno","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0023","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QAI.0000000000000069","article-title":"Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder","volume":"65","author":"Levine","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0024","first-page":"11","article-title":"Blood-brain barrier impairment in patients living with HIV: predictors and associated biomarkers","author":"Caligaris","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-63849-6.00007-4","article-title":"HIV-associated neurocognitive disorder","volume":"152","author":"Smail","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0026","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-022-00521-3","article-title":"Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease","volume":"17","author":"Visser","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0027","unstructured":"Wpcalc. https:\/\/wpcalc.com\/en\/equilibrium-hardy-weinberg\/."},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0028","article-title":"Antiretroviral levels in the cerebrospinal fluid: the effect of inflammation and genetic variants","volume":"13","author":"Cusato","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0029","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3851\/IMP3119","article-title":"Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?","volume":"22","author":"Cattaneo","year":"2016","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0000000000001558","article-title":"Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF","volume":"77","author":"Cattaneo","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0031","unstructured":"PharmGKB. Very important pharmacogene: ABCB1 2023."},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/2191-219X-2-57","article-title":"Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene","volume":"2","author":"van Assema","year":"2012","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0033","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dky481","article-title":"Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites","volume":"74","author":"Decloedt","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0034","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00403-018-1842-8","article-title":"Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T\/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid","volume":"310","author":"Rychlik-Sych","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ijantimicag.2024.107137_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0891988711402325","article-title":"ABCB1 genotype and CSF beta-amyloid in Alzheimer disease","volume":"24","author":"Kohen","year":"2011","journal-title":"J Geriatr Psychiatry Neurol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:51:59Z","timestamp":1716828719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0924857924000554"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107137","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107137"}}